Xspray Pharma AB (publ) (STO:XSPRAY)
Sweden · Delayed Price · Currency is SEK 15.34
-0.16 (-1.03%)
Jul 3, 2026, 5:29 PM CET
Xspray Pharma AB Market Cap
Xspray Pharma AB has a market cap or net worth of 727.37 million as of July 2, 2026. Its market cap has decreased by -50.67% in one year.
Market Cap
727.37M
Enterprise Value
754.50M
Revenue
2.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.34
Market Cap Chart
Since September 28, 2017, Xspray Pharma AB's market cap has increased from 375.71M to 727.37M, an increase of 93.60%. That is a compound annual growth rate of 7.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 727.37M | -44.59% |
| Dec 30, 2025 | 1.31B | -14.72% |
| Dec 30, 2024 | 1.54B | 23.14% |
| Dec 29, 2023 | 1.25B | -3.30% |
| Dec 30, 2022 | 1.29B | -2.48% |
| Dec 30, 2021 | 1.33B | -63.83% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medivir AB | 1.07B |
| SynAct Pharma AB | 1.05B |
| Infant Bacterial Therapeutics AB | 941.65M |
| AlzeCure Pharma AB | 712.47M |
| Oncopeptides AB | 649.85M |
| FluoGuide | 622.91M |
| Cantargia AB | 523.08M |
| Corline Biomedical AB | 482.16M |